Emiljan Mustaqe

Emiljan Mustaqe

Auto-generated profile, based on publicly available information

Emiljan Mustaqe

Agricultural University of Tirana

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2024 in Acta Scientiarum Polonorum. Oeconomia
Verified
Journal Article
Open access
PDF file
AGAlbana Gjoni
Albana Gjoni
EMEmiljan Mustaqe
Emiljan Mustaqe
ELEleana Lici
Eleana Lici
SNSilvana Nakuçi
Silvana Nakuçi
Aim: Green finance is a concept that is only partially known in Albania. However, Albania is committed to supporting green agreements for a planet that respects the environment and sustainability. For this reason, this paper aims to analyze the level of knowledge and awareness of Albanian people regarding green finance, the financial products that are part of green finance, the activities developed to promote green finance, as well as the expected results regarding the commitment towards a sustainable green world. Methods: In or­der to study the latest developments, a questionnaire was built, which was distributed at institutions that are related to sustainability activities or are responsible for sustainability reporting and also where the financial institutions that produce financial products that promote green finance operate. Results: The results of the study show an increasing trend of activities in support of sustainable development, but still relatively little recognition of the problems related to the emission of greenhouse gasses and climate change. Reporting about sustainability activities is in the process of being included in financial reporting standards. Conclusions: In conclusion, green finance in Albania is in its first steps and needs general awareness and involvement of all actors to make possible a quick transition to a sustainable economy and living. Reporting about sustainability activities is still voluntary and not mandatory; standards about sustainability reporting are still in progress and, when finalized, will help to boost all individuals and enterprises toward performing and reporting sus­tainability activities.

16 December 2024 in Medical Science and Discovery
Verified
Journal Article
Open access
EMEmiljan Mustaqe
Emiljan Mustaqe
ELElias Liolis
Elias Liolis
EBEleni Bekou
Eleni Bekou
LTLevan Tchabashvili
Levan Tchabashvili
KTKonstantinos Tasios
Konstantinos Tasios
Francesk MulitaFrancesk Mulita
Francesk Mulita
Objective: Butyrylcholinesterase (BChE) is an enzyme that shares similarities with acetylcholinesterase (AChE) but has been less studied due to its uncertain physiological role. Initially regarded as an ‘orphan enzyme,’ recent studies suggest that BChE plays a significant role in inflammation, primarily through its involvement in the cholinergic anti-inflammatory pathway. This enzyme, primarily produced by the liver, is found in several tissues and is known to hydrolyze acetylcholine, a neurotransmitter that modulates immune responses. BChE levels are influenced by various diseases, such as diabetes, cardiovascular diseases, and neurological disorders, which are associated with inflammation. This study reviews the costs of inflammatory biomarkers worldwide and investigates the association between BChE and inflammation. Data from multiple countries reveal varying costs for biomarkers like C-reactive protein (CRP), procalcitonin (PCT), and BChE, with BChE being a more cost-effective option in certain regions such as Greece and Armenia. Furthermore, BChE activity correlates inversely with the degree of systemic inflammation, and its levels may serve as a predictive marker for conditions such as surgical infections and anastomotic leaks. The findings underscore the potential of BChE as a useful and affordable biomarker for monitoring inflammation, particularly in settings where other biomarkers are more costly. However, further research is needed to validate its widespread clinical application.

16 December 2024 in Medical Science and Discovery
Verified
Journal Article
Open access
EMEmiljan Mustaqe
Emiljan Mustaqe
ELElias Liolis
Elias Liolis
EBEleni Bekou
Eleni Bekou
LTLevan Tchabashvili
Levan Tchabashvili
KTKonstantinos Tasios
Konstantinos Tasios
Francesk MulitaFrancesk Mulita
Francesk Mulita
Objective: Pain is a common and significant symptom in clinical practice, particularly among emergency and cancer patients. This article explores various pain scales and their clinical applications, alongside postoperative pain management in oncologic patients. A review of unidimensional pain scales, including the Numeric Rating Scale (NRS), Visual Analog Scale (VAS), Verbal Rating Scale (VRS), and Faces Pain Rating Scale (FPS), is presented. Additionally, the pathophysiology and pharmacological and non-pharmacological strategies for managing postoperative pain in cancer patients are discussed. Pain scales vary in sensitivity, ease of use, and clinical suitability. NRS is widely preferred for its simplicity and statistical applicability, whereas VAS offers higher sensitivity but practical limitations. Postoperative pain in oncologic patients is influenced by surgical trauma, psychological factors, and pre-existing pain conditions, with inadequate management leading to systemic complications and increased cancer recurrence risk. Effective management incorporates both non-opioid and opioid analgesics based on pain severity. Pain assessment tools and effective management strategies are critical for improving patient outcomes in clinical settings. Tailored approaches, particularly in oncologic postoperative care, can mitigate complications and enhance quality of life.